Medical Assisted Weight Loss

Medications have long been used to assist with weight loss, including amphetamines like phentermine. However, these substances are heavily regulated due to potential serious side effects. Newer options, such as glucagon-like peptide (GLP-1) agonists—marketed as Ozempic (semaglutide) and Mounjaro (tirzepatide)—offer a much better safety profile.

Our team closely monitors your blood levels to ensure safe administration of GLP-1 medications. The FDA allows compounding pharmacies to provide these medications at reduced costs, though this may not be a permanent option.

Patients receive a month’s worth of medication, starting on half doses weekly before gradually increasing to standard doses. Clinical data shows weight loss results of up to 10% with Ozempic and 20% with Mounjaro, though individual results may vary.